News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Moxie Dwight
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
4
| Moxie Dwight (SVP, GC & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 19,346 shares
@ $0
Paid exercise price by delivering 9,592 shares
@ $18.91, valued at
$181.4k
|
|
| 05/16/2023 |
4
| Moxie Dwight (SVP, GC & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 42,349 shares
@ $0
Sold 21,401 shares
@ $34.5469, valued at
$739.3k
|
|
| 05/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/17/2023 |
4
| Moxie Dwight (SVP, GC & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 7,330 shares
@ $30.65, valued at
$224.7k
|
|
| 03/09/2023 |
4
| Moxie Dwight (SVP, GC & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 42,349 shares
@ $0
Sold 18,496 shares
@ $31.5863, valued at
$584.2k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2022 |
4
| Moxie Dwight (SVP, GC & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Sold 11,000 shares
@ $27.0725, valued at
$297.8k
|
|
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Moxie Dwight (SVP, GC & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 68,093 options to buy
@ $13.08, valued at
$890.7k
|
|
| 09/28/2021 |
4
| Moxie Dwight (SVP, GC & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Sold 1,675 shares
@ $30, valued at
$50.3k
|
|
| 03/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2020 |
4
| Moxie Dwight (SVP, GC & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.|
Txns:
| Granted 12,250 shares
@ $0
Paid exercise price by delivering 4,236 shares
@ $25.14, valued at
$106.5k
|
|
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|